Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating reaffirmed by stock analysts at J P Morgan Chase & Co in a report released on Tuesday. They currently have a GBX 7,500 ($100.94) price target on the stock. J P Morgan Chase & Co’s target price indicates a potential upside of 11.31% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the stock. Goldman Sachs Group set a GBX 7,070 ($95.15) price objective on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research report on Monday. Barclays reiterated an “equal weight” rating and set a GBX 6,600 ($88.83) price objective (down from GBX 7,100 ($95.56)) on shares of Reckitt Benckiser Group in a research report on Monday, November 27th. Liberum Capital reiterated a “buy” rating and set a GBX 8,000 ($107.67) price objective on shares of Reckitt Benckiser Group in a research report on Sunday, November 26th. UBS set a GBX 7,000 ($94.21) price objective on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research report on Wednesday, November 1st. Finally, S&P Global set a GBX 7,500 ($100.94) price objective on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research report on Friday, October 20th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of GBX 7,723.64 ($103.95).

Reckitt Benckiser Group (RB) opened at GBX 6,738 ($90.69) on Tuesday. Reckitt Benckiser Group has a 12-month low of GBX 6,299 ($84.78) and a 12-month high of GBX 8,110.43 ($109.16).

In other news, insider Christopher Sinclair acquired 2,800 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 1st. The shares were bought at an average cost of GBX 6,597 ($88.79) per share, with a total value of £184,716 ($248,608.34). Also, insider Adrian Nevil Hennah acquired 2,285 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 8th. The stock was purchased at an average cost of GBX 6,567 ($88.38) per share, for a total transaction of £150,055.95 ($201,959.56).

COPYRIGHT VIOLATION NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/12/14/j-p-morgan-chase-co-reiterates-overweight-rating-for-reckitt-benckiser-group-rb.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Stock Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related stocks with our FREE daily email newsletter.